In the last 12 months, insiders at Avalo Therapeutics, Inc. ($AVTX) filed 198 transactions with the SEC: 40 open-market purchases totaling $1,709,000 and 32 sales totaling $8,589,316. Net insider sentiment: net selling.
Avalo Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Doyle Mittie (Chief Medical Officer) — 32 transactions totaling $4,407,213
- Sullivan Christopher Ryan (Chief Financial Officer) — 30 transactions totaling $2,630,911
- VARKI PAUL (Chief Legal Officer) — 13 transactions totaling $2,458,220
- ARMISTICE CAPITAL, LLC (TenPercentOwner) — 5 transactions totaling $2,170,216
- Caissa Capital Management ltd. (TenPercentOwner) — 34 transactions totaling $1,680,823
View all SEC Filings for Avalo Therapeutics, Inc. (AVTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Doyle Mittie | Chief Medical Officer | M | Common Stock | 3000 | $12.65 | 6,622.0000 | 18,133,968 | 82.83% | 0.02% |
| May 15, 2026 | Doyle Mittie | Chief Medical Officer | S | Common Stock | 3000 | $18.76 | 3,622.0000 | 18,133,968 | 45.30% | 0.02% |
| May 15, 2026 | Doyle Mittie | Chief Medical Officer | M | Stock Option (Right to Buy) | 3000 | $0.00 | 128,625.0000 | 18,133,968 | 2.28% | 0.02% |
| May 7, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M | Common Stock | 18606 | $9.88 | 19,029.0000 | 18,133,968 | 4398.58% | 0.10% |
| May 7, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S | Common Stock | 18606 | $24.12 | 423.0000 | 18,133,968 | 97.78% | 0.10% |
| May 7, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M | Stock Option (Right to Buy) | 18606 | $0.00 | 168,094.0000 | 18,133,968 | 9.97% | 0.10% |
| May 6, 2026 | VARKI PAUL | Chief Legal Officer | S | Common Stock | 9253 | $22.70 | 4,034.0000 | 18,133,968 | 69.64% | 0.05% |
| May 6, 2026 | VARKI PAUL | Chief Legal Officer | S | Common Stock | 400 | $23.71 | 3,634.0000 | 18,133,968 | 9.92% | 0.00% |
| May 6, 2026 | VARKI PAUL | Chief Legal Officer | M | Stock Option (Right to Buy) | 62500 | $0.00 | 87,500.0000 | 18,133,968 | 41.67% | 0.34% |
| May 6, 2026 | VARKI PAUL | Chief Legal Officer | M | Stock Option (Right to Buy) | 12563 | $0.00 | 87,437.0000 | 18,133,968 | 12.56% | 0.07% |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M | Common Stock | 47000 | $8.04 | 47,423.0000 | 18,133,968 | 9999.99% | 0.26% |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S | Common Stock | 13834 | $18.55 | 33,589.0000 | 18,133,968 | 29.17% | 0.08% |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S | Common Stock | 12347 | $19.28 | 21,242.0000 | 18,133,968 | 36.76% | 0.07% |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S | Common Stock | 2700 | $20.76 | 18,542.0000 | 18,133,968 | 12.71% | 0.01% |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S | Common Stock | 9219 | $21.37 | 9,323.0000 | 18,133,968 | 49.72% | 0.05% |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S | Common Stock | 8900 | $22.57 | 423.0000 | 18,133,968 | 95.46% | 0.05% |
| May 6, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M | Stock Option (Right to Buy) | 47000 | $0.00 | 116,000.0000 | 18,133,968 | 28.83% | 0.26% |
| May 5, 2026 | Doyle Mittie | Chief Medical Officer | M | Common Stock | 1000 | $12.65 | 4,622.0000 | 18,133,968 | 27.61% | 0.01% |
| May 5, 2026 | Doyle Mittie | Chief Medical Officer | M | Common Stock | 679 | $8.04 | 5,301.0000 | 18,133,968 | 14.69% | 0.00% |
| May 5, 2026 | Doyle Mittie | Chief Medical Officer | S | Common Stock | 1679 | $16.00 | 3,622.0000 | 18,133,968 | 31.67% | 0.01% |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | M | Common Stock | 77905 | $12.65 | 81,527.0000 | 18,133,968 | 2150.88% | 0.43% |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | S | Common Stock | 10058 | $22.88 | 3,622.0000 | 18,133,968 | 73.52% | 0.06% |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | S | Common Stock | 27538 | $18.03 | 82,639.0000 | 18,133,968 | 24.99% | 0.15% |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | S | Common Stock | 5000 | $19.65 | 77,639.0000 | 18,133,968 | 6.05% | 0.03% |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | S | Common Stock | 44944 | $21.20 | 32,695.0000 | 18,133,968 | 57.89% | 0.25% |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | S | Common Stock | 19015 | $22.41 | 13,680.0000 | 18,133,968 | 58.16% | 0.10% |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | M | Common Stock | 28650 | $8.04 | 110,177.0000 | 18,133,968 | 35.14% | 0.16% |
| May 6, 2026 | VARKI PAUL | Chief Legal Officer | M | Common Stock | 62500 | $13.43 | 66,134.0000 | 18,133,968 | 1719.87% | 0.34% |
| May 6, 2026 | VARKI PAUL | Chief Legal Officer | M | Common Stock | 12563 | $8.04 | 78,697.0000 | 18,133,968 | 19.00% | 0.07% |
| May 6, 2026 | VARKI PAUL | Chief Legal Officer | S | Common Stock | 37375 | $18.91 | 41,322.0000 | 18,133,968 | 47.49% | 0.21% |
| May 6, 2026 | VARKI PAUL | Chief Legal Officer | S | Common Stock | 5196 | $19.78 | 36,126.0000 | 18,133,968 | 12.57% | 0.03% |
| May 6, 2026 | VARKI PAUL | Chief Legal Officer | S | Common Stock | 22839 | $21.22 | 13,287.0000 | 18,133,968 | 63.22% | 0.13% |
| May 6, 2026 | Chan Mitchell | Not found | S | Common Stock | 3167 | $22.88 | 3,166.0000 | 18,133,968 | 50.01% | 0.02% |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | M | Stock Option (Right to Buy) | 28650 | $0.00 | 119,000.0000 | 18,133,968 | 19.40% | 0.16% |
| May 6, 2026 | Doyle Mittie | Chief Medical Officer | M | Stock Option (Right to Buy) | 77905 | $0.00 | 131,625.0000 | 18,133,968 | 37.18% | 0.43% |
| May 5, 2026 | Doyle Mittie | Chief Medical Officer | M | Stock Option (Right to Buy) | 679 | $0.00 | 147,650.0000 | 18,133,968 | 0.46% | 0.00% |
| May 5, 2026 | Doyle Mittie | Chief Medical Officer | M | Stock Option (Right to Buy) | 1000 | $0.00 | 209,530.0000 | 18,133,968 | 0.47% | 0.01% |
| April 30, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S | Common Stock | 8457 | $13.23 | 423.0000 | 18,133,968 | 95.24% | 0.05% |
| April 29, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S | Common Stock | 8458 | $13.09 | 8,880.0000 | 18,133,968 | 48.78% | 0.05% |
| April 6, 2026 | Doyle Mittie | Chief Medical Officer | M | Stock Option (Right to Buy) | 3970 | $0.00 | 210,530.0000 | 18,133,968 | 1.85% | 0.02% |
| April 6, 2026 | Doyle Mittie | Chief Medical Officer | S | Common Stock | 3970 | $18.01 | 3,622.0000 | 18,133,968 | 52.29% | 0.02% |
| April 6, 2026 | Doyle Mittie | Chief Medical Officer | M | Common Stock | 3970 | $12.65 | 7,592.0000 | 18,133,968 | 109.61% | 0.02% |
| April 1, 2026 | Doyle Mittie | Chief Medical Officer | M | Common Stock | 679 | $8.04 | 4,301.0000 | 18,133,968 | 18.75% | 0.00% |
| April 2, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S | Common Stock | 1780 | $17.57 | 17,338.0000 | 18,133,968 | 9.31% | 0.01% |
| April 2, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S | Common Stock | 6200 | $17.02 | 19,118.0000 | 18,133,968 | 24.49% | 0.03% |
| April 1, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S | Common Stock | 7479 | $16.83 | 25,318.0000 | 18,133,968 | 22.80% | 0.04% |
| April 1, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S | Common Stock | 500 | $15.86 | 32,797.0000 | 18,133,968 | 1.50% | 0.00% |
| April 1, 2026 | Doyle Mittie | Chief Medical Officer | M | Stock Option (Right to Buy) | 679 | $0.00 | 148,329.0000 | 18,133,968 | 0.46% | 0.00% |
| April 1, 2026 | Doyle Mittie | Chief Medical Officer | S | Common Stock | 679 | $16.00 | 3,622.0000 | 18,133,968 | 15.79% | 0.00% |
| March 31, 2026 | Jain Rita | Not found | A | Stock Option (Right to Buy) | 1339 | $12.13 | 1,339.0000 | 18,133,968 | 9999.99% | 0.01% |
| March 31, 2026 | Lind Kevin Robert | Not found | A | Stock Option (Right to Buy) | 1370 | $12.13 | 1,370.0000 | 18,133,968 | 9999.99% | 0.01% |
| March 28, 2026 | KANTOFF AARON | Not found | M | Restricted Stock Units | 3166 | $0.00 | 3,167.0000 | 18,133,968 | 49.99% | 0.02% |
| March 28, 2026 | Truex Samantha | Not found | M | Common Stock | 3166 | $0.00 | 6,333.0000 | 18,133,968 | 99.97% | 0.02% |
| March 28, 2026 | Truex Samantha | Not found | M | Restricted Stock Units | 3166 | $0.00 | 3,167.0000 | 18,133,968 | 49.99% | 0.02% |
| March 28, 2026 | KANTOFF AARON | Not found | M | Common Stock | 3166 | $0.00 | 6,333.0000 | 18,133,968 | 99.97% | 0.02% |
| March 28, 2026 | Chan Mitchell | Not found | M | Common Stock | 3166 | $0.00 | 6,333.0000 | 18,133,968 | 99.97% | 0.02% |
| March 28, 2026 | Chan Mitchell | Not found | M | Restricted Stock Units | 3166 | $0.00 | 3,167.0000 | 18,133,968 | 49.99% | 0.02% |
| March 28, 2026 | Goldman Jonathan | Not found | M | Common Stock | 3166 | $0.00 | 3,166.0000 | 18,133,968 | 9999.99% | 0.02% |
| March 28, 2026 | Goldman Jonathan | Not found | M | Restricted Stock Units | 3166 | $0.00 | 3,167.0000 | 18,133,968 | 49.99% | 0.02% |
| March 28, 2026 | KAPLAN GILLA | Not found | M | Restricted Stock Units | 3166 | $0.00 | 3,167.0000 | 18,133,968 | 49.99% | 0.02% |
| March 28, 2026 | NEIL GARRY ARTHUR | Chief Executive Officer | M | Common Stock | 64866 | $0.00 | 112,006.0000 | 18,133,968 | 137.60% | 0.36% |
| March 28, 2026 | NEIL GARRY ARTHUR | Chief Executive Officer | F | Common Stock | 21892 | $13.89 | 90,114.0000 | 18,133,968 | 19.55% | 0.12% |
| March 28, 2026 | NEIL GARRY ARTHUR | Chief Executive Officer | M | Restricted Stock Units | 64866 | $0.00 | 64,867.0000 | 18,133,968 | 50.00% | 0.36% |
| March 28, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M | Common Stock | 24200 | $0.00 | 41,538.0000 | 18,133,968 | 139.58% | 0.13% |
| March 28, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M | Restricted Stock Units | 24200 | $0.00 | 24,200.0000 | 18,133,968 | 50.00% | 0.13% |
| March 28, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | F | Common Stock | 8241 | $13.89 | 33,297.0000 | 18,133,968 | 19.84% | 0.05% |
| March 28, 2026 | KAPLAN GILLA | Not found | M | Common Stock | 3166 | $0.00 | 6,333.0000 | 18,133,968 | 99.97% | 0.02% |
| March 16, 2026 | Doyle Mittie | Chief Medical Officer | S | Common Stock | 25492 | $16.15 | 3,622.0000 | 18,133,968 | 87.56% | 0.14% |
| March 16, 2026 | Doyle Mittie | Chief Medical Officer | M | Stock Option (Right to Buy) | 5992 | $0.00 | 149,008.0000 | 18,133,968 | 3.87% | 0.03% |
| March 16, 2026 | Doyle Mittie | Chief Medical Officer | M | Common Stock | 19500 | $12.65 | 23,122.0000 | 18,133,968 | 538.38% | 0.11% |
| March 16, 2026 | Doyle Mittie | Chief Medical Officer | M | Common Stock | 5992 | $8.04 | 29,114.0000 | 18,133,968 | 25.91% | 0.03% |
| March 16, 2026 | Doyle Mittie | Chief Medical Officer | M | Stock Option (Right to Buy) | 19500 | $0.00 | 214,500.0000 | 18,133,968 | 8.33% | 0.11% |
| Feb. 26, 2026 | NEIL GARRY ARTHUR | Chief Executive Officer | A | Stock Option (Right to Buy) | 286000 | $0.00 | 286,000.0000 | 18,133,968 | 9999.99% | 1.58% |
| Feb. 26, 2026 | Riley Jennifer | Chief Strategy Officer | A | Stock Option (Right to Buy) | 95000 | $0.00 | 95,000.0000 | 18,133,968 | 9999.99% | 0.52% |
| Feb. 26, 2026 | Doyle Mittie | Chief Medical Officer | A | Stock Option (Right to Buy) | 105000 | $0.00 | 105,000.0000 | 18,133,968 | 9999.99% | 0.58% |
| Feb. 26, 2026 | Boyd Taylor | Chief Business Officer | A | Stock Option (Right to Buy) | 95000 | $0.00 | 95,000.0000 | 18,133,968 | 9999.99% | 0.52% |
| Feb. 26, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | A | Stock Option (Right to Buy) | 105000 | $0.00 | 105,000.0000 | 18,133,968 | 9999.99% | 0.58% |
| Feb. 26, 2026 | VARKI PAUL | Chief Legal Officer | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 18,133,968 | 9999.99% | 0.44% |
| Dec. 31, 2025 | Jain Rita | Director | A | Stock Option (Right to Buy) | 1043 | $14.74 | 1,043.0000 | 18,133,968 | 9999.99% | 0.01% |
| Dec. 31, 2025 | Lind Kevin Robert | Director | A | Stock Option (Right to Buy) | 848 | $14.74 | 848.0000 | 18,133,968 | 9999.99% | 0.00% |
| Dec. 10, 2025 | Doyle Mittie | Chief Medical Officer | F | Common Stock | 1013 | $4.10 | 3,622.0000 | 18,133,968 | 21.86% | 0.01% |
| Dec. 10, 2025 | Sullivan Christopher Ryan | Chief Financial Officer | F | Common Stock | 155 | $4.10 | 17,338.0000 | 18,133,968 | 0.89% | 0.00% |
| Dec. 10, 2025 | VARKI PAUL | Chief Legal Officer | F | Common Stock | 1016 | $4.10 | 3,634.0000 | 18,133,968 | 21.85% | 0.01% |
| Dec. 10, 2025 | Riley Jennifer | Chief Strategy Officer | F | Common Stock | 637 | $4.10 | 2,655.0000 | 18,133,968 | 19.35% | 0.00% |
| Nov. 14, 2025 | Goldman Jonathan | Director | M | Stock Option (Right to Buy) | 8200 | $0.00 | 16,400.0000 | 18,133,968 | 33.33% | 0.05% |
| Nov. 14, 2025 | Goldman Jonathan | Director | S | Common Stock | 8200 | $14.35 | 0.0000 | 18,133,968 | 100.00% | 0.05% |
| Nov. 14, 2025 | Goldman Jonathan | Director | M | Common Stock | 8200 | $9.88 | 8,200.0000 | 18,133,968 | 9999.99% | 0.05% |
| Nov. 14, 2025 | Goldman Jonathan | Director | S | Common Stock | 3167 | $14.30 | 0.0000 | 18,133,968 | 100.00% | 0.02% |
| Oct. 1, 2025 | Boyd Taylor | Chief Business Officer | A | Stock Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 10,671,934 | 9999.99% | 2.58% |
| Sept. 30, 2025 | Jain Rita | Director | A | Stock Option (Right to Buy) | 1572 | $0.00 | 1,572.0000 | 10,671,934 | 9999.99% | 0.01% |
| Oct. 1, 2025 | Lind Kevin Robert | Director | A | Stock Option (Right to Buy) | 40200 | $0.00 | 40,200.0000 | 10,671,934 | 9999.99% | 0.38% |
| June 17, 2025 | Jain Rita | Director | A | Stock Option (Right to Buy) | 40200 | $0.00 | 40,200.0000 | 10,671,934 | 9999.99% | 0.38% |
| June 17, 2025 | Chan Mitchell | Director | A | Stock Option (Right to Buy) | 20100 | $0.00 | 20,100.0000 | 10,671,934 | 9999.99% | 0.19% |
| June 17, 2025 | Goldman Jonathan | Director | A | Stock Option (Right to Buy) | 20100 | $0.00 | 20,100.0000 | 10,671,934 | 9999.99% | 0.19% |
| June 17, 2025 | KAPLAN GILLA | Director | A | Stock Option (Right to Buy) | 20100 | $0.00 | 20,100.0000 | 10,671,934 | 9999.99% | 0.19% |
| June 17, 2025 | KANTOFF AARON | Director | A | Stock Option (Right to Buy) | 20100 | $0.00 | 20,100.0000 | 10,671,934 | 9999.99% | 0.19% |
| June 17, 2025 | Heffernan Michael Thomas | Director | A | Stock Option (Right to Buy) | 29500 | $0.00 | 29,500.0000 | 10,671,934 | 9999.99% | 0.28% |
| June 17, 2025 | Almenoff June Sherie | Director | A | Stock Option (Right to Buy) | 20100 | $0.00 | 20,100.0000 | 10,671,934 | 9999.99% | 0.19% |
| June 17, 2025 | Truex Samantha | Director | A | Stock Option (Right to Buy) | 20100 | $0.00 | 20,100.0000 | 10,671,934 | 9999.99% | 0.19% |
| March 28, 2025 | Almenoff June Sherie | Director | M | Restricted Stock Units | 3167 | $0.00 | 6,333.0000 | 10,671,934 | 33.34% | 0.03% |
| March 28, 2025 | Chan Mitchell | Director | M | Common Stock | 3167 | $0.00 | 3,167.0000 | 10,671,934 | 9999.99% | 0.03% |
| March 28, 2025 | Chan Mitchell | Director | M | Restricted Stock Units | 3167 | $0.00 | 6,333.0000 | 10,671,934 | 33.34% | 0.03% |
| March 28, 2025 | Goldman Jonathan | Director | M | Common Stock | 3167 | $0.00 | 3,167.0000 | 10,671,934 | 9999.99% | 0.03% |
| March 28, 2025 | Goldman Jonathan | Director | M | Restricted Stock Units | 3167 | $0.00 | 6,333.0000 | 10,671,934 | 33.34% | 0.03% |
| March 28, 2025 | Truex Samantha | Director | M | Common Stock | 3167 | $0.00 | 3,167.0000 | 10,671,934 | 9999.99% | 0.03% |
| March 28, 2025 | Truex Samantha | Director | M | Restricted Stock Units | 3167 | $0.00 | 6,333.0000 | 10,671,934 | 33.34% | 0.03% |
| March 28, 2025 | KANTOFF AARON | Director | M | Common Stock | 3167 | $0.00 | 3,167.0000 | 10,671,934 | 9999.99% | 0.03% |
| March 28, 2025 | KANTOFF AARON | Director | M | Restricted Stock Units | 3167 | $0.00 | 6,333.0000 | 10,671,934 | 33.34% | 0.03% |
| March 28, 2025 | KAPLAN GILLA | Director | M | Common Stock | 3167 | $0.00 | 3,167.0000 | 10,671,934 | 9999.99% | 0.03% |
| March 28, 2025 | KAPLAN GILLA | Director | M | Restricted Stock Units | 3167 | $0.00 | 6,333.0000 | 10,671,934 | 33.34% | 0.03% |
| March 28, 2025 | Almenoff June Sherie | Director | M | Common Stock | 3167 | $0.00 | 4,167.0000 | 10,671,934 | 316.70% | 0.03% |
| March 28, 2025 | Sullivan Christopher Ryan | Chief Financial Officer | M | Common Stock | 24200 | $0.00 | 24,206.0000 | 10,671,934 | 9999.99% | 0.23% |
| March 28, 2025 | Sullivan Christopher Ryan | Chief Financial Officer | F | Common Stock | 7285 | $8.46 | 16,921.0000 | 10,671,934 | 30.10% | 0.07% |
| March 28, 2025 | Sullivan Christopher Ryan | Chief Financial Officer | M | Restricted Stock Units | 24200 | $0.00 | 48,400.0000 | 10,671,934 | 33.33% | 0.23% |
| March 28, 2025 | NEIL GARRY ARTHUR | Chief Executive Officer | M | Common Stock | 64867 | $0.00 | 64,927.0000 | 10,671,934 | 9999.99% | 0.61% |
| March 28, 2025 | NEIL GARRY ARTHUR | Chief Executive Officer | F | Common Stock | 17787 | $8.46 | 47,140.0000 | 10,671,934 | 27.40% | 0.17% |
| March 28, 2025 | NEIL GARRY ARTHUR | Chief Executive Officer | M | Restricted Stock Units | 64867 | $0.00 | 129,733.0000 | 10,671,934 | 100.00% | 0.61% |
| March 25, 2025 | Heffernan Michael Thomas | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 10,671,934 | 9999.99% | 0.47% |
| Jan. 28, 2025 | NEIL GARRY ARTHUR | CEO and Chairman of the Board | A | Stock Option (Right to Buy) | 411000 | $0.00 | 411,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Doyle Mittie | Chief Medical Officer | A | Stock Option (Right to Buy) | 155000 | $0.00 | 155,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Sullivan Christopher Ryan | Chief Financial Officer | A | Stock Option (Right to Buy) | 163000 | $0.00 | 163,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | VARKI PAUL | Chief Legal Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2025 | Riley Jennifer | Chief Strategy Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 13, 2024 | Almenoff June Sherie | Director | P | Common Stock | 500 | $13.00 | 1,000.0000 | 0 | 100.00% | 0.00% |
| Nov. 12, 2024 | Almenoff June Sherie | Director | P | Common Stock | 500 | $12.50 | 500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | KANTOFF AARON | Director | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Truex Samantha | Director | A | Stock Option (Right to Buy) | 24600 | $0.00 | 24,600.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Truex Samantha | Director | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | KAPLAN GILLA | Director | A | Stock Option (Right to Buy) | 24600 | $0.00 | 24,600.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Goldman Jonathan | Director | A | Stock Option (Right to Buy) | 24600 | $0.00 | 24,600.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Goldman Jonathan | Director | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Chan Mitchell | Director | A | Stock Option (Right to Buy) | 24600 | $0.00 | 24,600.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Chan Mitchell | Director | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Almenoff June Sherie | Director | A | Stock Option (Right to Buy) | 24600 | $0.00 | 24,600.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Almenoff June Sherie | Director | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | KANTOFF AARON | Director | A | Stock Option (Right to Buy) | 24600 | $0.00 | 24,600.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | KAPLAN GILLA | Director | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Sullivan Christopher Ryan | Chief Financial Officer | A | Stock Option (Right to Buy) | 186700 | $0.00 | 186,700.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Sullivan Christopher Ryan | Chief Financial Officer | A | Restricted Stock Units | 72600 | $0.00 | 72,600.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | NEIL GARRY ARTHUR | CEO and Chairman of the Board | A | Stock Option (Right to Buy) | 500400 | $0.00 | 500,400.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | NEIL GARRY ARTHUR | CEO and Chairman of the Board | A | Restricted Stock Units | 194600 | $0.00 | 194,600.0000 | 0 | 9999.99% | 0.00% |
| July 15, 2024 | Doyle Mittie | Chief Medical Officer | A | Stock Option (Right to Buy) | 234000 | $0.00 | 234,000.0000 | 0 | 9999.99% | 0.00% |
| June 24, 2024 | VARKI PAUL | Chief Legal Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 20, 2023 | Chan Mitchell | Director | A | Stock Option (Right to Buy) | 3334 | $0.00 | 3,334.0000 | 0 | 9999.99% | 0.00% |
| Dec. 20, 2023 | Persson Magnus | Director | A | Stock Option (Right to Buy) | 3334 | $0.00 | 3,334.0000 | 0 | 9999.99% | 0.00% |
| Dec. 20, 2023 | Almenoff June Sherie | Director | A | Stock Option (Right to Buy) | 3334 | $0.00 | 3,334.0000 | 0 | 9999.99% | 0.00% |
| Dec. 20, 2023 | KAPLAN GILLA | Director | A | Stock Option (Right to Buy) | 3334 | $0.00 | 3,334.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Persson Magnus | Director | A | Stock Option (Right to Buy) | 28308 | $0.00 | 28,308.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Almenoff June Sherie | Director | A | Stock Option (Right to Buy) | 4575 | $0.00 | 4,575.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2023 | ARMISTICE CAPITAL, LLC | TenPercentOwner | S | Common Stock | 937404 | $0.52 | 765,828.0000 | 0 | 55.04% | 0.00% |
| June 26, 2023 | ARMISTICE CAPITAL, LLC | TenPercentOwner | S | Common Stock | 2746138 | $0.61 | 1,703,232.0000 | 0 | 61.72% | 0.00% |
| June 26, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 182300 | $0.62 | 0.0000 | 0 | 100.00% | 0.00% |
| June 26, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 1425700 | $0.64 | 0.0000 | 0 | 100.00% | 0.00% |
| June 15, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 3160 | $3.68 | 1,603,000.0000 | 0 | 0.20% | 0.00% |
| June 20, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 2000 | $4.14 | 1,608,000.0000 | 0 | 0.12% | 0.00% |
| June 16, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 3000 | $3.90 | 1,606,000.0000 | 0 | 0.19% | 0.00% |
| June 13, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 8750 | $3.82 | 1,593,840.0000 | 0 | 0.55% | 0.00% |
| June 14, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 6000 | $3.48 | 1,599,840.0000 | 0 | 0.38% | 0.00% |
| June 12, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 2149 | $4.34 | 1,585,090.0000 | 0 | 0.14% | 0.00% |
| June 9, 2023 | Sullivan Christopher Ryan | Chief Financial Officer | P | Common Stock | 511 | $3.42 | 1,262.0000 | 0 | 68.04% | 0.00% |
| June 9, 2023 | NEIL GARRY ARTHUR | CEO and Chairman of the Board | P | Common Stock | 4000 | $3.42 | 13,220.0000 | 0 | 43.38% | 0.00% |
| June 7, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 2984 | $3.49 | 1,571,499.0000 | 0 | 0.19% | 0.00% |
| June 8, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 6398 | $3.93 | 1,577,897.0000 | 0 | 0.41% | 0.00% |
| June 9, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 5044 | $4.14 | 1,582,941.0000 | 0 | 0.32% | 0.00% |
| May 31, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 844 | $2.87 | 1,568,515.0000 | 0 | 0.05% | 0.00% |
| May 25, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common stock | 2000 | $2.77 | 1,567,000.0000 | 0 | 0.13% | 0.00% |
| May 30, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common stock | 671 | $2.87 | 1,567,671.0000 | 0 | 0.04% | 0.00% |
| May 24, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 3481 | $3.01 | 1,559,481.0000 | 0 | 0.22% | 0.00% |
| May 24, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 5519 | $2.96 | 1,565,000.0000 | 0 | 0.35% | 0.00% |
| May 19, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common stock | 6500 | $3.52 | 1,549,000.0000 | 0 | 0.42% | 0.00% |
| May 18, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common stock | 13121 | $3.29 | 1,542,500.0000 | 0 | 0.86% | 0.00% |
| May 22, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common stock | 7000 | $3.34 | 1,556,000.0000 | 0 | 0.45% | 0.00% |
| May 15, 2023 | Sullivan Christopher Ryan | Chief Financial Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2023 | NEIL GARRY ARTHUR | CEO and Chairman of the Board | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common stock | 1715 | $2.55 | 1,529,000.0000 | 0 | 0.11% | 0.00% |
| May 12, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common stock | 2285 | $2.45 | 1,527,285.0000 | 0 | 0.15% | 0.00% |
| May 16, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common stock | 379 | $2.75 | 1,529,379.0000 | 0 | 0.02% | 0.00% |
| May 5, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 5000 | $2.88 | 1,520,000.0000 | 0 | 0.33% | 0.00% |
| May 4, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 15000 | $2.79 | 1,515,000.0000 | 0 | 1.00% | 0.00% |
| May 8, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 5000 | $2.62 | 1,525,000.0000 | 0 | 0.33% | 0.00% |
| April 26, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 425 | $2.97 | 1,498,496.0000 | 0 | 0.03% | 0.00% |
| April 25, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 5571 | $3.00 | 1,498,071.0000 | 0 | 0.37% | 0.00% |
| April 27, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 1504 | $2.96 | 1,500,000.0000 | 0 | 0.10% | 0.00% |
| April 20, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 5000 | $3.08 | 1,480,000.0000 | 0 | 0.34% | 0.00% |
| April 24, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 12500 | $3.06 | 1,492,500.0000 | 0 | 0.84% | 0.00% |
| April 17, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 15000 | $2.96 | 1,465,000.0000 | 0 | 1.03% | 0.00% |
| April 18, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 10000 | $2.94 | 1,475,000.0000 | 0 | 0.68% | 0.00% |
| April 10, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 31329 | $2.28 | 1,425,000.0000 | 0 | 2.25% | 0.00% |
| April 11, 2023 | Caissa Capital Management ltd. | TenPercentOwner | P | Common Stock | 25000 | $2.84 | 1,450,000.0000 | 0 | 1.75% | 0.00% |
| March 31, 2023 | Almenoff June Sherie | Director | A | Stock Option (Right to Buy) | 1167 | $0.00 | 1,167.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2023 | Persson Magnus | Director | A | Stock Option (Right to Buy) | 7222 | $0.00 | 7,222.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2023 | Sullivan Christopher Ryan | Chief Financial Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2023 | NEIL GARRY ARTHUR | CEO and Chairman of the Board | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 7, 2023 | ARMISTICE CAPITAL, LLC | TenPercentOwner | P | Common Stock | 450000 | $0.00 | 4,449,370.0000 | 0 | 11.25% | 0.00% |
| Feb. 3, 2023 | ARMISTICE CAPITAL, LLC | TenPercentOwner | L | Common Stock | 334 | $3.95 | 3,999,370.0000 | 0 | 0.01% | 0.00% |
| Feb. 7, 2023 | ARMISTICE CAPITAL, LLC | TenPercentOwner | P | Warrant | 450000 | $0.00 | 450,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 30, 2022 | Almenoff June Sherie | Director | A | Stock Option (Right to Buy) | 410 | $0.00 | 410.0000 | 0 | 9999.99% | 0.00% |
| Dec. 30, 2022 | Persson Magnus | Director | A | Stock Option (Right to Buy) | 2536 | $0.00 | 2,536.0000 | 0 | 9999.99% | 0.00% |